Creatine phosphate protects the myocardium of acute coronary syndrome patients after percutaneous coronary intervention

YANG Ji-yu,GONG Jian-bin,WANG Li-jun,PENG Yong-ping,CHENG Xun-min,JIANG Shi-sen,ZHANG Qi-gao,KONG Na-na
DOI: https://doi.org/10.3969/j.issn.1008-8199.2012.03.012
2012-01-01
Abstract:Objective Percutaneous coronary intervention(PCI) has been applied widely in clinical practice for several years.How to effectively reduce myocardial reperfusion injury is one of the issues to be addressed.The authors observed the myocardium protecting effect of creatine phosphate(CrP) in patients with acute coronary syndrome(ACS) after PCI.Methods A total of 180 ACS patients treated by PCI were equally randomly into a control group [56 males,34 females and aged(65.3±12.6)yr] and a treatment group [53 males,37 females and aged(63.6±12.4)yr],the former given conventional medication before and after PCI,while the latter intravenous injection of CrP for 5 days after PCI in addition to conventional medication.We detected the levels of CK-MB,LDH,cTnT,SOD,MDA and NO in the serum of all the patients before and after PCI.Results The treatment group showed a significantly higher level of serum SOD [41.2(10.3-168.2)pg/ml and remarkably lower levels of serum MDA,LDH and CK-MB 3.22(1.00-7.84)pg/ml],[156.2(84.0-703.5)U/L and 11.0(5.0-104.0)U/L] than the control group [32.4(10.5-96.8)pg/ml,3.67(0.58-9.82)pg/ml];[176.5(94.0-983.7)U/L and 14.5(5.0-196.5)U/L,P<0.01].There were no statistically significant differences between the two groups in the levels of cTnT and NO [1.25(0.01-8.5)ng/ml vs 1.37(0.01-9.2)ng/ml and 165.5(22.5-437.7)umol/L vs 159.6(20.3-414.4)umol/L,P>0.05].Conclusion CrP could protect the myocardium of ACS patients after PCI.
What problem does this paper attempt to address?